Publishing its sixth annual report into the management of controlled drugs, the CQC said attention from CCGs and controlled drugs accountable officers was ‘critical’ if vigilance over controlled drugs was not to be lost during the NHS’s transition period.
From April this year the CQC took over responsibility for assessing governance arrangements for prescribing controlled drugs from PCTs.
The CQC said ‘good progress’ had been made in the past six years on regulations introduced in the wake of Harold Shipman’s murders, and it warned that this must not be lost.
CQC chief executive David Behan, said: ‘As new systems and processes bed in across the NHS it is vital that vigilance is maintained to ensure the safety of patients.
‘It is important and absolutely correct that CQC looks at the governance arrangements for controlled drugs in primary medical services now we are the regulator for these services.’